Tejara Capital Ltd bought a new position in shares of Evolent Health, Inc (NYSE:EVH – Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 1,331,441 shares of the technology company’s stock, valued at approximately $5,326,000. Evolent Health accounts for approximately 1.3% of Tejara Capital Ltd’s holdings, making the stock its 16th largest holding. Tejara Capital Ltd owned about 1.19% of Evolent Health at the end of the most recent quarter.
A number of other institutional investors have also recently added to or reduced their stakes in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Evolent Health by 2.9% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 128,527 shares of the technology company’s stock worth $1,217,000 after acquiring an additional 3,572 shares during the period. CIBC Private Wealth Group LLC increased its position in Evolent Health by 4,000.0% during the 3rd quarter. CIBC Private Wealth Group LLC now owns 4,100 shares of the technology company’s stock valued at $35,000 after purchasing an additional 4,000 shares during the period. Strs Ohio bought a new position in Evolent Health during the 1st quarter worth approximately $47,000. Headlands Technologies LLC bought a new position in Evolent Health during the 2nd quarter worth approximately $58,000. Finally, Congress Asset Management Co. raised its holdings in Evolent Health by 2.8% during the 4th quarter. Congress Asset Management Co. now owns 193,657 shares of the technology company’s stock worth $775,000 after purchasing an additional 5,300 shares during the last quarter.
Analysts Set New Price Targets
A number of analysts have commented on EVH shares. TD Cowen reaffirmed a “buy” rating on shares of Evolent Health in a research report on Monday, March 2nd. KeyCorp lowered Evolent Health from an “overweight” rating to a “sector weight” rating in a research report on Wednesday, February 25th. Wall Street Zen raised Evolent Health from a “sell” rating to a “hold” rating in a research note on Saturday, February 28th. BMO Capital Markets restated an “outperform” rating and set a $3.50 target price on shares of Evolent Health in a research report on Wednesday, February 25th. Finally, BTIG Research decreased their target price on Evolent Health from $10.00 to $8.00 and set a “buy” rating for the company in a research note on Wednesday, February 25th. Thirteen analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Evolent Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $5.88.
Evolent Health Stock Down 0.9%
Shares of NYSE:EVH opened at $4.09 on Friday. The company has a debt-to-equity ratio of 2.46, a quick ratio of 1.32 and a current ratio of 1.32. Evolent Health, Inc has a 52-week low of $2.10 and a 52-week high of $12.06. The business’s 50 day simple moving average is $3.01 and its two-hundred day simple moving average is $3.67. The firm has a market cap of $456.72 million, a P/E ratio of -0.86 and a beta of 0.83.
Evolent Health (NYSE:EVH – Get Free Report) last issued its earnings results on Thursday, May 7th. The technology company reported ($0.02) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.03. The company had revenue of $496.25 million for the quarter, compared to analyst estimates of $534.00 million. Evolent Health had a positive return on equity of 0.36% and a negative net margin of 26.29%.Evolent Health’s revenue for the quarter was up 2.6% on a year-over-year basis. During the same period in the prior year, the firm earned $0.06 earnings per share. As a group, research analysts forecast that Evolent Health, Inc will post -0.23 EPS for the current fiscal year.
Evolent Health Company Profile
Evolent Health, Inc is a U.S.-based healthcare technology and services company that partners with health systems, physician organizations and health plans to design, build and operate value-based care programs. Headquartered in Arlington, Virginia, the company was founded in 2011 as a joint venture between TPG and the University of Pittsburgh Medical Center (UPMC). Evolent Health aims to help its clients transition from fee-for-service payment models to value-based care arrangements by leveraging its proprietary technology platforms and clinical expertise.
The company’s core offerings include care management solutions, population health analytics and clinical advisory services.
Recommended Stories
- Five stocks we like better than Evolent Health
- YETI Rallies After Earnings Beat and Raised Outlook
- How the 3 Leading Quantum Firms Stack Up After Q1 Earnings
- Cisco’s Vertical Rally May Still Be in the Early Innings
- Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now
Want to see what other hedge funds are holding EVH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Evolent Health, Inc (NYSE:EVH – Free Report).
Receive News & Ratings for Evolent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health and related companies with MarketBeat.com's FREE daily email newsletter.
